Stay updated on HY209 Gel Phase I Clinical Trial
Sign up to get notified when there's something new on the HY209 Gel Phase I Clinical Trial page.

Latest updates to the HY209 Gel Phase I Clinical Trial page
- Check6 days agoChange DetectedNo substantive changes to the study details were detected; the page content remains the same aside from minor UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check13 days agoNo Change Detected
- Check35 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior version tag v3.1.0 was removed.SummaryDifference4%

- Check42 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

- Check56 days agoChange DetectedMinor update: Revision updated from v3.0.1 to v3.0.2, and the Back to Top link was removed; no significant changes to core content, pricing, stock, or time slots.SummaryDifference0.2%

- Check63 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.3%

- Check70 days agoChange DetectedThe web page has updated its facility name and location details, specifically clarifying the location as Seoul, South Korea, and has added new medical topics related to congenital and skin diseases.SummaryDifference4%

Stay in the know with updates to HY209 Gel Phase I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HY209 Gel Phase I Clinical Trial page.